Search

Tutorial on acute leukemia held in Istanbul

EHA and the Turkish Society of Hematology (TSH) partnered for the seventh time to organize a tutorial.

Read more

Treatment of acute lymphoblastic leukemia by activation of patient's immune cells by a bispecific antibody.

 

Abstract S722
Acute lymphoblastic leukemia  (ALL) is a rare type of blood cancer which is mainly treated by intensive chemotherapy.

Read more

Chairs and Members

ChairUwe Platzbecker, University of Leipzig, Medical Faculty, Clinic and Polyclinic for Hematology, Cellular Therapy and Hemostaseology (Germany)

Co-chairLionel Adès, Hôpital Saint-Louis Paris, Hématologie Seniors (France)

SWG Steering Committee
Pierre Fenaux, Hôpital Saint-Louis, Hématologie Seniors, Paris (France)
Arjan van de Loosdrecht, Amsterdam UMC, Hematology (The…

Read more

Genome sequencing of thousands of patients with rare blood disorders

Approximately 3M people have a rare bleeding disorder or disease of platelets, which are the cell fragments that help blood clot. The genetic causes of dozens of such disorders are known (e. g.

Read more

EHA Awards 2011 at the 16th Congress of EHA in London

Bob Löwenberg will be the fourth recipient of the Jean Bernard Lifetime Achievement Award which was presented for the first time at the 13th Annual Congress in Copenhagen.

Read more

EHA Mentorship Program

A new, career-focused program that provides individual mentoring support for early and mid-career clinicians and researchers in hematology. The call for mentees closed on February 20, 2025.

Read more

EHA Innovation Grant review and selection process

1. Eligibility checkAfter the deadline has passed, we'll check your application for completion and compliance with the eligibility criteria.

Read more